Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Crespo

Showing results (311-320 of 366) with videos related to

Pageof 37
Sort By:
Molecular Metabolism|July 15, 2023
Hepatocyte-specific O-GlcNAc transferase downregulation ameliorates nonalcoholic steatohepatitis by improving mitochondrial functionMaria J Gonzalez-Rellan, Tamara Parracho, Violeta Heras, et al.
Journal of Hepatology|February 15, 2022
Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosisMarcos F Fondevila, Uxia Fernandez, Violeta Heras, et al.
Journal of Hepatology|March 10, 2020
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASHJavier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.
Journal of Hepatology|July 14, 2020
Erratum to: "Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17-25)Javier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.
Hepatology Communications|July 21, 2018
Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohortsRebeca Mayo, Javier Crespo, Ibon Martínez-Arranz, et al.
Cell Reports. Medicine|February 10, 2024
p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathwayMarcos F Fondevila, Eva Novoa, Maria J Gonzalez-Rellan, et al.
Hepatology (Baltimore, Md.)|February 8, 2017
Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registryCarlos Fernández Carrillo, Sabela Lens, Elba Llop, et al.
Revista Espanola De Enfermedades Digestivas|December 14, 2022
Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liverJoaquín Cabezas, Javier Crespo, Antonio Aguilera, et al.
Alimentary Pharmacology & Therapeutics|June 3, 2025
Occurrence and Management of Opportunistic Infections in Patients With Autoimmune Hepatitis: A Spanish Multicentre StudyMaría Del Barrio, Elena Ferreiro, Elena Gómez, et al.
Science Advances|October 22, 2025
Metabolic dysfunction-associated steatotic liver disease alters brain function and behavior: Insights from liver-targeted siRNA therapyTeresa Cardoso Delgado, Celia Martín-Cuevas, Ana C Sánchez Hidalgo, et al.
Pageof 37

Showing results (311-320 of 366) with videos related to

Sort By:
Pageof 37
Molecular Metabolism|July 15, 2023
Hepatocyte-specific O-GlcNAc transferase downregulation ameliorates nonalcoholic steatohepatitis by improving mitochondrial functionMaria J Gonzalez-Rellan, Tamara Parracho, Violeta Heras, et al.
Journal of Hepatology|February 15, 2022
Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosisMarcos F Fondevila, Uxia Fernandez, Violeta Heras, et al.
Journal of Hepatology|March 10, 2020
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASHJavier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.
Journal of Hepatology|July 14, 2020
Erratum to: "Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17-25)Javier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.
Hepatology Communications|July 21, 2018
Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohortsRebeca Mayo, Javier Crespo, Ibon Martínez-Arranz, et al.
Cell Reports. Medicine|February 10, 2024
p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathwayMarcos F Fondevila, Eva Novoa, Maria J Gonzalez-Rellan, et al.
Hepatology (Baltimore, Md.)|February 8, 2017
Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registryCarlos Fernández Carrillo, Sabela Lens, Elba Llop, et al.
Revista Espanola De Enfermedades Digestivas|December 14, 2022
Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liverJoaquín Cabezas, Javier Crespo, Antonio Aguilera, et al.
Alimentary Pharmacology & Therapeutics|June 3, 2025
Occurrence and Management of Opportunistic Infections in Patients With Autoimmune Hepatitis: A Spanish Multicentre StudyMaría Del Barrio, Elena Ferreiro, Elena Gómez, et al.
Science Advances|October 22, 2025
Metabolic dysfunction-associated steatotic liver disease alters brain function and behavior: Insights from liver-targeted siRNA therapyTeresa Cardoso Delgado, Celia Martín-Cuevas, Ana C Sánchez Hidalgo, et al.
Pageof 37